Neil Hayes

24PUBLICATIONS
235CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 02, 2026
Genetically Proxied Inhibition of Cholesterol-Lowering Drug Targets and Survival in HPV-Positive and Non-HPV-Driven Head and Neck Cancer: A Multicentre MR Study.

|Mar 11, 2026
Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment.

Sofia Ferreira, Brittany M Flowers, Won-Young Choi

|Mar 06, 2026
The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial.

Joanne B Weidhaas, Jonathan Harris, Maura L Gillison

|Sep 26, 2025
Lung Adenocarcinoma Just Desserts: An Expanding Pie of Activating Oncogenes or a Layer Cake of Integrated Alterations.

Minjeong Kim, Wisut Lamlertthon, Heejoon Jo

|Dec 10, 2024
Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer.

Li Guan, Pedro A Torres-Saavedra, Xiaobei Zhao

|Sep 07, 2024
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study.

Abhinav Thakral, John Jw Lee, Tianzhichao Hou

Pageof 4